In vivo adhesion of a K88ab-positive enterotoxigenic Escherichia coli (ETEC) strain to the small intestinal wall of gnotobiotic, colostrum-deprived Chinese and Large White piglets was investigated. A non-enterotoxigenic, attachment factor-deprived E. coli strain, inoculated in association with the K88ab ETEC strain, was used as a marker to determine the content residues on the intestinal walls of gnotobiotic piglets. Both strains were selectively numerated in the luminal contents and on the washed wall from three segments of the small intestine. In vivo attachment was assessed by the ratio between the number of K88ab ETEC adherent to the wall and the number of both the E. coli strains which came from the luminal content residues and were not completely removed by washing. This ratio was first calculated in one group of 8 Large White piglets associated with the marker strain and with a K88ab antigen-deprived E. coli which derived from the parental K88ab ETEC strain. Thus, the range of the ratio was determined in those piglets where no attachment was expected. A comparison between the latter values of the ratio and the values obtained from 15 Large White and 10 Chinese piglets inoculated with the marker strain and the K88ab ETEC strain allowed us to classify the Large White piglets into adhesive (8 piglets) and non-adhesive (7 piglets) phenotypes and to show that the 10 Chinese piglets belonged to the non-adhesive phenotype.

Download full-text PDF

Source
http://dx.doi.org/10.1051/rnd:19850105DOI Listing

Publication Analysis

Top Keywords

large white
20
etec strain
16
k88ab etec
16
chinese piglets
12
white piglets
12
piglets
10
white chinese
8
vivo attachment
8
enterotoxigenic escherichia
8
escherichia coli
8

Similar Publications

Peripheral inflammatory markers (PIMs), such as C-reactive protein (CRP) or white blood cell count (WBC), have been associated with depression severity in meta-analyses and large cohort studies. However, in typically-sized psychoimmunology studies (N < 200) that explore associations between PIMs and neurobiological/psychosocial constructs related to depression and studies that examine less-studied PIMs (e.g.

View Article and Find Full Text PDF

Objective: To explore how women who used substances during the perinatal period perceived the care they received from interprofessional perinatal care providers.

Design: Appreciative inquiry.

Setting: Interprofessional perinatal care clinic in a large urban tertiary care hospital in Canada.

View Article and Find Full Text PDF

Pharmacogenetic Testing in Admixed Populations: Frequency of the AMR PGx Working Group Tier 1 Variant Alleles in Brazilians.

J Mol Diagn

January 2025

Clinical Research and Technological Development Division (Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico), Brazilian National Cancer Institute (Instituto Nacional de Câncer), Rio de Janeiro, Brazil. Electronic address:

This article examines the frequency distribution of Tier 1 pharmacogenetic variants of the Association for Molecular Pathology Pharmacogenomics Working Group Recommendations in two large (>1.000 individuals) cohorts of the admixed Brazilian population, and in patients from the Brazilian Public Health System enrolled in pharmacogenetic trials. Three Tier 1 variants, all in DPYD, were consistently absent, which may justify their non-inclusion in genotyping panels for Brazilians; 13 variants had frequency < 1.

View Article and Find Full Text PDF

The 18 Workshop on Recent Issues in Bioanalysis (18 WRIB) took place in San Antonio, TX, USA on May 6-10, 2024. Over 1100 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest in bioanalysis. The 18 WRIB included 3 Main Workshops and 7 Specialized Workshops that together spanned 1 week to allow an exhaustive and thorough coverage of all major issues in bioanalysis of biomarkers, immunogenicity, gene therapy, cell therapy and vaccines.

View Article and Find Full Text PDF

The 18 Workshop on Recent Issues in Bioanalysis (18 WRIB) took place in San Antonio, TX, USA on May 6-10, 2024. Over 1100 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest in bioanalysis. The 18 WRIB included 3 Main Workshops and 7 Specialized Workshops that together spanned 1 week to allow an exhaustive and thorough coverage of all major issues in bioanalysis of biomarkers, immunogenicity, gene therapy, cell therapy and vaccines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!